Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Tumori|October 7, 2024
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology NetworkAndrea Boutros, Nidia Sofia Diaz Gaitan, Giovanni Orengo, et al.
European Heart Journal|April 24, 2012
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathyAttilio Iacovoni, Paolo Spirito, Caterina Simon, et al.
European Journal of Pediatrics|February 16, 2026
Effect of delayed cord clamping and cord milking on cerebral oxygenation and cardiovascular function: a secondary analysis of the PCI trialSimone Pratesi, Stefano Ghirardello, Cristiana Germini, et al.
Journal of the American College of Cardiology|June 17, 2026
Long-Term Outcome of Myectomy Associated With Secondary Mitral Valve Chordal Cutting in Obstructive Hypertrophic CardiomyopathyPaolo Ferrazzi, Paolo Spirito, Irene Binaco, et al.
Cancer Chemotherapy and Pharmacology|August 12, 2011
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancerFrancesco Grossi, Filippo de Marinis, Vittorio Gebbia, et al.
Infection|April 15, 2018
Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year periodJessica Mencarini, Elisabetta Mantengoli, Lorenzo Tofani, et al.
Cancer Letters|July 19, 2005
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectivesWendy B London, Luca Boni, Thorsten Simon, et al.
Journal of the National Cancer Institute|June 7, 2007
Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysisAndrea Ardizzoni, Luca Boni, Marcello Tiseo, et al.
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative groupMarco Benasso, Anna Ponzanelli, Marco Merlano, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2013
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancerFrancesca Mazzoni, Fabiana Letizia Cecere, Giulia Meoni, et al.
Pageof 15